FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16098011000001104: Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Nov 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1737441000001116 Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1737451000001118 Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) Is a Desloratadine 2.5mg/5ml oral solution sugar free true Inferred relationship Existential restriction modifier
Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) Has active ingredient Desloratadine true Inferred relationship Existential restriction modifier
Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) Has specific active ingredient Desloratadine true Inferred relationship Existential restriction modifier
Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) Is a Neoclarityn true Inferred relationship Existential restriction modifier
Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) Has manufactured dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) 150 ml Has AMP True Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) 225 ml Has AMP False Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) 100 ml Has AMP True Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start